Today, Explained

Skinny and sad on GLP-1s

February 13, 2026·25 min·4-min readconversationalhealth
Podzilla Summary (4 min)
TLDR
The podcast explores the surge in popularity of GLP-1 weight-loss drugs like semaglutide (Ozempic, Wegovy), their availability through compounding pharmacies, and emerging psychological side effects such as emotional flatness and loss of motivation. While these drugs offer life-changing b

Sign up to read the full summary

Free AI-powered recaps of every episode, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.

Guest

D

Dr. Sarah Lavelle

conversational on Today, Explained

Mentions

Books, people, and resources mentioned in this episode.

People

Sydney LepkinJohn Gwynne HillDr. Sarah Lavelle

Companies

Novo NordiskHims

Products & Tools

WegovyOzempicsemaglutideFDA

Topics

BiohackingLongevityMental HealthNutritionWeight Loss

Listen to This Episode

Get summaries like this every morning.

Free AI-powered recaps of Today, Explained and your other favorite podcasts, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.